Change Healthcare Inc. CHNG reported first-quarter fiscal 2022 adjusted earnings per share (EPS) of 41 cents, which missed the Zacks Consensus Estimate of 46 cents by 10.9%. Nonetheless, the bottom line improved 64% on a year-over-year basis.Net loss per share was 1 cent in the quarter, much narrower that the year-ago quarter’s loss of 18 cents.Revenue DetailsRevenues climbed 25% from the prior-year period to $867.9 million in the reported quarter. The top line outpaced the Zacks Consensus Estimate by 2.3%.Segmental AnalysisChange Healthcare operates through three segments — Software and Analytics, Network Solutions, Technology-Enabled Services and Postage and Eliminations.Software and AnalyticsRevenues at this segment totaled $420.3 million, up 7.3% on a year-over-year basis.Network SolutionsRevenues at this segment were $209.5 million, up 46.7% year over year.McKesson Corporation Price, Consensus and EPS Surprise McKesson Corporation price-consensus-eps-surprise-chart | McKesson Corporation QuoteTechnology-Enabled ServicesRevenues at this segment amounted to $225.5 million, up 20.1% year over year.Postage and EliminationsRevenues at this segment totaled $17 million, down 37.1% year over year.Margin AnalysisTotal operating expenses were $823.7 million, up 17.4% from the prior-year quarter.In the quarter under review, Change Healthcare reported operating income of $44.1 million, against the year-ago quarter’s operating loss of $7.7 million.Financial PositionThe company exited the quarter with cash and cash equivalents of $109.1 million, compared with $113.1 million in the preceding quarter.Cash provided operating activities at the end of fiscal first quarter amounted to $110.1 million compared with $169.1 million in the year-ago period.GuidanceGiven the proposed merger agreement (with OptumInsight), Change Healthcare will not be issuing financial guidance going forward.Wrapping UpChange Healthcare exited first-quarter fiscal 2022 on a mixed note, wherein earnings missed the Zacks Consensus Estimate but revenues beat the same. The company exhibited robust performance across Software and Analytics, Network Solutions and Technology-Enabled segments in the quarter under review.However, cut-throat competition remains a concern. Weak performance at the Postage and Eliminations segment is a woe. Higher operating expenses is concerning.Zacks RankCurrently, Change Healthcare carries a Zacks Rank #2 (Buy).Earnings of Other MedTech Majors at a GlanceSome better-ranked stocks in the broader medical space that have already announced their quarterly results are Encompass Health Corporation EHC, West Pharmaceutical Services, Inc. WST and Hill-Rom Holdings, Inc. HRC. While Encompass Health sports a Zacks Rank #1 (Strong Buy), both West Pharmaceutical and Hill-Rom carry a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.Encompass Health reported second-quarter 2021 adjusted EPS of $1.17, which beat the Zacks Consensus Estimate by 15.8%. Second-quarter revenues of $1.3 billion outpaced the consensus mark by 1.5%.West Pharmaceutical reported second-quarter 2021 adjusted EPS of $2.46, which surpassed the Zacks Consensus Estimate by 41.4%. Second-quarter revenues of $723.6 million outpaced the Zacks Consensus Estimate by 8.7%.Hill-Rom reported third-quarter fiscal 2021 adjusted EPS of $1.38, which beat the Zacks Consensus Estimate by 2.9%. Fiscal third-quarter revenues of $717.7 million outpaced the consensus mark by 1.6%. Bitcoin, Like the Internet Itself, Could Change Everything Blockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the “Internet of Money” and predict it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree we’re still in the early stages of this technology, and as it grows, it will create several investing opportunities. Zacks’ has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly. See 3 crypto-related stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report West Pharmaceutical Services, Inc. (WST): Free Stock Analysis Report HillRom Holdings, Inc. (HRC): Free Stock Analysis Report Encompass Health Corporation (EHC): Free Stock Analysis Report Change Healthcare Inc. (CHNG): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research